Literature DB >> 6218942

Plasminogen activator release during venous stasis and exercise as determined by a new specific assay.

B Wiman, G Mellbring, M Rånby.   

Abstract

A method for the specific determination of tissue plasminogen activator in plasma samples has been developed. The method is based on a recently described parabolic rate assay for tissue plasminogen activator (Rånby and Wallén, 1980) measuring plasmin activity by a chromogenic tripeptide-paranitroanilide substrate. The potential interference by plasmin inhibitors in plasma is overcome by acidification of the plasma samples to pH 4 for 15 min prior to the analysis. The baseline activity (after 10 min of rest) in 22 healthy individuals was determined to be 0.05 +/- 0.03 (SD) IU/ml (0.2 +/- 0.1 ng/ml). After venous occlusion for 10 min at 100 mm Hg the activator concentrations had increased to 1.2 +/- 1.2 (SD) IU/ml (5.2 +/- 5.2 ng/ml). Furthermore, prior to venous occlusion almost no plasmin-alpha 2-antiplasmin complex was found in the samples, whereas a pronounced increase in this complex was noted in 90% of the subjects after venous occlusion. During exercise, a gradual work-load dependent increase of tissue plasminogen activator concentration was observed. At maximal work-load the concentration was 2.3 +/- 1.9 (SD) IU/ml (9.9 +/- 8.1 ng/ml active enzyme), which after 10 min rest decreased to 26 +/- 12 (SD) % of the values at maximal work-load. In these samples only small amounts of plasmin-alpha 2-antiplasmin complex were detected, although the activator content was of the same order of magnitude as after venous occlusion.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6218942     DOI: 10.1016/s0009-8981(83)80012-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  24 in total

1.  The effect of calcium and magnesium ions on urinary urokinase and sialidase activity.

Authors:  C H van Aswegen; J C Dirksen van Sckalckwyk; P J du Toit; L Verster; R C Franz; D J du Plessis
Journal:  Urol Res       Date:  1992

2.  Effects of doxazosin and atenolol on the fibrinolytic system in patients with hypertension and elevated serum cholesterol.

Authors:  J H Jansson; B Johansson; K Boman; T K Nilsson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Effect of prolonged physical exercise on the fibrinolytic system.

Authors:  L Röcker; M Taenzer; W K Drygas; H Lill; B Heyduck; H U Altenkirch
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1990

4.  Binding of tissue plasminogen activator to human aortic endothelial cells.

Authors:  M A Sanzo; S C Howard; A J Wittwer; H M Cochrane
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

5.  Determination of C1s-C1 inhibitor complexes in plasma by means of an enzyme linked immunosorbent assay.

Authors:  T Nilsson; O Bäck
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

6.  The effect of different exercise intensities on the fibrinolytic system.

Authors:  A B Molz; B Heyduck; H Lill; E Spanuth; L Röcker
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1993

7.  Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.

Authors:  D J Pinsky; H Liao; C A Lawson; S F Yan; J Chen; P Carmeliet; D J Loskutoff; D M Stern
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

8.  Effect of benazepril amlodipine combination on fibrinolysis in hypertensive diabetic patients.

Authors:  Roberto Fogari; Paola Preti; Pierangelo Lazzari; Luca Corradi; Annalisa Zoppi; Elena Fogari; Amedeo Mugellini
Journal:  Eur J Clin Pharmacol       Date:  2003-06-27       Impact factor: 2.953

9.  Plasminogen activator inhibitor: a risk factor for myocardial infarction in diabetic patients.

Authors:  R P Gray; J S Yudkin; D L Patterson
Journal:  Br Heart J       Date:  1993-03

10.  Pyelonephritis: renal urokinase activity in rats on essential fatty acid diets.

Authors:  P J du Toit; C H van Aswegen; J D Nel; B Strasheim; P J Becker; D J du Plessis
Journal:  Urol Res       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.